Cargando…
500. Impact of an iron chelator on in vitro and in vivo growth of A. baumannii
BACKGROUND: Acinetobacter baumannii (AB) has become multidrug-resistant in recent years and currently there is no consensus on the optimal treatment for these infections. To combat this urgent threat, novel treatment options are needed to minimize spread and lower mortality rates. Nutrient metals (e...
Autores principales: | Eales, Brianna, Bai, Bing, Tam, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751536/ http://dx.doi.org/10.1093/ofid/ofac492.557 |
Ejemplares similares
-
2767. Impact of iron limitation on in vitro and in vivo activity of ceftazidime against A. baumannii
por: Eales, Brianna, et al.
Publicado: (2023) -
Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii
por: Bai, Bing, et al.
Publicado: (2022) -
Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci
por: Kim, Choon-Mee, et al.
Publicado: (2009) -
Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo
por: Shinoda, Shuhei, et al.
Publicado: (2018) -
2542. Attenuation of Polymyxin and Aminoglycoside-Associated Nephrotoxicity
por: Hudson, Cole, et al.
Publicado: (2023)